Immunomodulatory aspects in the progression and treatment of oral malignancy
Inflammation substantially affects the risk of oral malignancy. Pro-inflammatory cytokine, interferon (IFN)-γ, confers anti-tumor activity using several different mechanisms. Conversely, higher expression of interleukin (IL)-17 is associated with worse prognosis. Monocyte chemotactic protein (MCP)-1...
Main Authors: | Nobuo Kondoh, Masako Mizuno-Kamiya, Naoki Umemura, Eiji Takayama, Harumi Kawaki, Kenji Mitsudo, Yasunori Muramatsu, Shinichiro Sumitomo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-11-01
|
Series: | Japanese Dental Science Review |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1882761619300559 |
Similar Items
-
Suppressive effect of mesenchymal stromal cells on interferon-γ-producing capability of spleen cells was specifically enhanced through humoral mediator(s) from mouse oral squamous cell carcinoma Sq-1979 Cells In Vitro
by: Toshihiro Inagaki, et al.
Published: (2018-01-01) -
The producing capabilities of Interferon-γ and Interleukin-10 of spleen cells in primary and metastasized oral squamous cell carcinoma cells-implanted mice
by: Yasuka Azuma, et al.
Published: (2017-01-01) -
Immunomodulatory Drugs for the Treatment of B Cell Malignancies
by: Nikolaos Ioannou, et al.
Published: (2021-08-01) -
The shape of progress
by: Masahito Sumitomo
Published: (2018-02-01) -
TNFα Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model
by: Jeffrey W. Chadwick, et al.
Published: (2021-09-01)